| 1 | 17129588 | Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1. | Life Sci | 2007 Jan 30 |
5 |
| 2 | 17566147 | Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. | Planta Med | 2007 May |
2 |
| 3 | 17950515 | Molecular mechanism of apoptosis induced by schizandrae-derived lignans in human leukemia HL-60 cells. | Food Chem Toxicol | 2008 Feb |
5 |
| 4 | 20448858 | Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity. | Methods Find Exp Clin Pharmacol | 2010 Apr |
6 |
| 5 | 20628932 | Synthesis and MDR inhibitory activity evaluation of derivatives of schizandrin A. | J Asian Nat Prod Res | 2010 Jul |
1 |
| 6 | 20664957 | Deoxyschisandrin inhibits H2O2-induced apoptotic cell death in intestinal epithelial cells through nuclear factor-kappaB. | Int J Mol Med | 2010 Sep |
6 |
| 7 | 21351579 | [Dual effects of extract of Schisandra chinensis Baill on rat hepatic CYP3A]. | Yao Xue Xue Bao | 2010 Sep |
2 |
| 8 | 21895978 | Inhibitory effects of continuous ingestion of Schisandrin A on CYP3A in the rat. | Basic Clin Pharmacol Toxicol | 2012 Feb |
3 |
| 9 | 23339253 | Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction. | Fitoterapia | 2012 Dec |
3 |
| 10 | 23691032 | Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay. | PLoS One | 2013 |
1 |
| 11 | 24131672 | Deoxyschizandrin, a naturally occurring lignan, is a specific probe substrate of human cytochrome P450 3A. | Drug Metab Dispos | 2014 Jan |
7 |
| 12 | 24475039 | Schisandra chinensis peptidoglycan-assisted transmembrane transport of lignans uniquely altered the pharmacokinetic and pharmacodynamic mechanisms in human HepG2 cell model. | PLoS One | 2014 |
1 |
| 13 | 24786236 | Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitro. | Acta Pharmacol Sin | 2014 May |
1 |
| 14 | 24855828 | Identification of CYP2C19 inhibitors from phytochemicals using the recombinant human enzyme model. | Pharmazie | 2014 May |
1 |
| 15 | 24986222 | Neuroprotective effect of schizandrin A on oxygen and glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons. | J Physiol Biochem | 2014 Sep |
2 |
| 16 | 24992201 | The protective mechanism of schisandrin A in d-galactosamine-induced acute liver injury through activation of autophagy. | Pharm Biol | 2014 Oct |
7 |
| 17 | 25975095 | Schisandrin A and B induce organic anion transporting polypeptide 1B1 transporter activity. | Pharmazie | 2015 Jan |
4 |
| 18 | 26919063 | Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling Pathways. | PLoS One | 2016 |
9 |
| 19 | 27195753 | Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response. | PLoS One | 2016 |
1 |
| 20 | 28604846 | Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach. | Mol Biosyst | 2017 Jul 25 |
4 |
| 21 | 28945011 | Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. | Basic Clin Pharmacol Toxicol | 2018 Mar |
2 |
| 22 | 29115385 | Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling. | Int J Mol Med | 2018 Jan |
10 |
| 23 | 29181822 | Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. | Breast Cancer | 2018 Mar |
6 |
| 24 | 29331856 | RETRACTED: Schizandrin A enhances chemosensitivity of colon carcinoma cells to 5-fluorouracil through up-regulation of miR-195. | Biomed Pharmacother | 2018 Mar |
1 |
| 25 | 29342940 | Deoxyschizandrin, Isolated from Schisandra Berries, Induces Cell Cycle Arrest in Ovarian Cancer Cells and Inhibits the Protumoural Activation of Tumour-Associated Macrophages. | Nutrients | 2018 Jan 15 |
7 |
| 26 | 29359345 | Simultaneous identification of the anaphylactoid components from traditional Chinese medicine injections using rat basophilic leukemia 2H3 and laboratory of allergic disease 2 dual-mixed/cell membrane chromatography model. | Electrophoresis | 2018 May |
1 |
| 27 | 29405807 | Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3. | Xenobiotica | 2019 Feb |
8 |
| 28 | 29911779 | [Inhibitory effect and mechanism of deoxyschizandrin on NLRP3 inflammasome]. | Yao Xue Xue Bao | 2017 Jan |
10 |
| 29 | 30119261 | Schisandrin A prevents oxidative stress-induced DNA damage and apoptosis by attenuating ROS generation in C2C12 cells. | Biomed Pharmacother | 2018 Oct |
2 |
| 30 | 30486721 | Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from <i>Schisandra chinensis</i>. | Xenobiotica | 2019 Nov |
1 |
| 31 | 30761007 | Schisandrin A Inhibits the IL-1β-Induced Inflammation and Cartilage Degradation via Suppression of MAPK and NF-κB Signal Pathways in Rat Chondrocytes. | Front Pharmacol | 2019 |
10 |
| 32 | 30787979 | Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. | Am J Transl Res | 2019 |
3 |
| 33 | 30909188 | Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429. | Cancer Biomark | 2019 |
1 |
| 34 | 31028739 | Schizandrin A enhances the efficacy of gefitinib by suppressing IKKβ/NF-κB signaling in non-small cell lung cancer. | Eur J Pharmacol | 2019 Jul 15 |
13 |
| 35 | 31552591 | Schisandrin A ameliorates MPTP-induced Parkinson's disease in a mouse model via regulation of brain autophagy. | Arch Pharm Res | 2019 Nov |
6 |
| 36 | 31597329 | Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway. | Molecules | 2019 Oct 8 |
12 |
| 37 | 31618367 | Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19. | Braz J Med Biol Res | 2019 |
11 |
| 38 | 31767544 | Schisandrin A protects against lipopolysaccharide-induced mastitis through activating Nrf2 signaling pathway and inducing autophagy. | Int Immunopharmacol | 2020 Jan |
11 |
| 39 | 31794890 | Schizandrin A Protects Human Retinal Pigment Epithelial Cell Line ARPE-19 against HG-Induced Cell Injury by Regulation of miR-145. | Mol Ther Nucleic Acids | 2020 Mar 6 |
16 |
| 40 | 31844123 | Schisandrin A protects intestinal epithelial cells from deoxynivalenol-induced cytotoxicity, oxidative damage and inflammation. | Sci Rep | 2019 Dec 16 |
2 |
| 41 | 31871476 | Effects of Deoxyschisandrin on Visceral Sensitivity of Mice with Inflammatory Bowel Disease. | Evid Based Complement Alternat Med | 2019 |
5 |
| 42 | 32057180 | MEG3 is restored by schisandrin A and represses tumor growth in choriocarcinoma cells. | J Biochem Mol Toxicol | 2020 Apr |
11 |
| 43 | 32058027 | Schizandrin attenuates lung lesions induced by Avian pathogenic Escherichia coli in chickens. | Microb Pathog | 2020 Feb 11 |
5 |
| 44 | 32076762 | Evidence of anti-inflammatory activity of Schizandrin A in animal models of acute inflammation. | Naunyn Schmiedebergs Arch Pharmacol | 2020 Nov |
1 |
| 45 | 32110802 | Schizandrin A exhibits potent anticancer activity in colorectal cancer cells by inhibiting heat shock factor 1. | Biosci Rep | 2020 Mar 27 |
5 |
| 46 | 32274105 | Schisandra A ameliorates cigarette smoke extract and lipopolysaccharide-induced oxidative stress in lung epithelial cells. | J Thorac Dis | 2020 Mar |
2 |
| 47 | 32354126 | Preventive Effects of Schisandrin A, A Bioactive Component of <i>Schisandra chinensis</i>, on Dexamethasone-Induced Muscle Atrophy. | Nutrients | 2020 Apr 28 |
8 |
| 48 | 32623835 | Schizandrin A inhibits cellular phenotypes of breast cancer cells by repressing miR-155. | IUBMB Life | 2020 Aug |
6 |
| 49 | 32871020 | Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling. | Cell Prolif | 2020 Oct |
15 |
| 50 | 33232930 | Interactions of the major effective components in Shengmai formula with breast cancer resistance protein at the cellular and vesicular levels. | Biomed Pharmacother | 2021 Jan |
1 |